New York State Common Retirement Fund
RXRX icon

New York State Common Retirement Fund’s Recursion Pharmaceuticals RXRX Stock Holding History

New York State Common Retirement Fund’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$560K Buy
152,575
+45,100
+42% +$150K ﹤0.01% 1965
2026
Q1 		$330K Hold
107,475
– – ﹤0.01% 2055
2025
Q4 		$440K Hold
107,475
– – ﹤0.01% 2010
2025
Q3 		$524K Hold
107,475
– – ﹤0.01% 1933
2025
Q2 		$544K Buy
107,475
+30,300
+39% +$149K ﹤0.01% 1879
2025
Q1 		$408K Buy
77,175
+13,800
+22% +$101K ﹤0.01% 1951
2024
Q4 		$428K Hold
63,375
– – ﹤0.01% 1995
2024
Q3 		$418K Sell
63,375
-21,500
-25% -$154K ﹤0.01% 2005
2024
Q2 		$637K Buy
84,875
+27,419
+48% +$239K ﹤0.01% 1947
2024
Q1 		$573K Sell
57,456
-958
-2% -$10.7K ﹤0.01% 2023
2023
Q4 		$576K Buy
58,414
+10,177
+21% +$72.6K ﹤0.01% 2041
2023
Q3 		$369K Buy
48,237
+5,879
+14% +$58.6K ﹤0.01% 2174
2023
Q2 		$316K Sell
42,358
-28,732
-40% -$201K ﹤0.01% 2305
2023
Q1 		$474K Sell
71,090
-23,882
-25% -$189K ﹤0.01% 2202
2022
Q4 		$732K Sell
94,972
-5
-0% -$49 ﹤0.01% 2126
2022
Q3 		$1.01M Buy
94,977
+345
+0.4% +$3.49K ﹤0.01% 1964
2022
Q2 		$770K Buy
94,632
+14,212
+18% +$95.1K ﹤0.01% 2158
2022
Q1 		$576K Buy
80,420
+12,903
+19% +$137K ﹤0.01% 2350
2021
Q4 		$1.16M Buy
67,517
+53,114
+369% +$999K ﹤0.01% 2053
2021
Q3 		$331K Sell
14,403
-3,697
-20% -$105K ﹤0.01% 2682
2021
Q2 		$661K Buy
+18,100
New +$536K ﹤0.01% 2445

Other funds holding RXRX

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
IEFM
IQ EQ Fund Management Dublin 2, Ireland $1.57B AUM 40.42% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
CI
Carroll Investors Mt Pleasant, South Carolina $234M AUM 59.79% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return
AO
Allen Operations New York $722M AUM 20.02% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

New York State Common Retirement Fund's RXRX Position: Q2 2026 in Review

New York State Common Retirement Fund increased its Recursion Pharmaceuticals (RXRX) stake by 42% in Q2 2026, buying an estimated $150K and bringing the position to 152,575 shares worth $560K. The position accounts for ﹤0.01% of the portfolio, ranked #1965.

New York State Common Retirement Fund first reported a position in RXRX in Q2 2021 and has held it in 21 quarters since. The position peaked at $1.16M in Q4 2021. 130 funds tracked by Wall St. Rank hold RXRX as of Q2 2026.

  • New York State Common Retirement Fund held 152,575 shares of Recursion Pharmaceuticals worth $560K as of Q2 2026.
  • New York State Common Retirement Fund bought 45,100 Recursion Pharmaceuticals shares in Q2 2026, an estimated $150K.
  • Recursion Pharmaceuticals made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #1965 holding.
  • New York State Common Retirement Fund first reported a position in Recursion Pharmaceuticals in Q2 2021 and has held it in 21 quarters since.
  • New York State Common Retirement Fund's Recursion Pharmaceuticals position peaked at $1.16M in Q4 2021.
  • 130 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.